Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT06389305What this trial is testingCIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell DysfunctionWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid Leukemia Beijing GoBroad Hospital 213
Testing effectiveness (Phase 2)Study completedNCT00073931What this trial is testingIodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Fred Hutchinson Cancer Center 25
Early research (Phase 1)WithdrawnNCT04094766What this trial is testingSafety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic LeukemiaWho this might be right forRefractory B Acute Lymphoblastic LeukemiaRelapse B Acute Lymphoblastic Leukemia Second Affiliated Hospital of Xi'an Jiaotong University
Testing effectiveness (Phase 2)UnknownNCT05164042What this trial is testingAllogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaWho this might be right forRelapse LeukemiaRefractory Leukemia Shenzhen University General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06533579What this trial is testingGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Who this might be right forB-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic Leukemia+10 more Vironexis Biotherapeutics Inc. 32
Early research (Phase 1)UnknownNCT04007978What this trial is testingAnti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell MalignanciesWho this might be right forB Cell LymphomaAcute Lymphoblastic Leukemia Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Early research (Phase 1)Study completedNCT00002818What this trial is testingHigh-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesWho this might be right forDrug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more Virginia Commonwealth University 15
Early research (Phase 1)Study completedNCT00080925What this trial is testingT-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more National Institutes of Health Clinical Center (CC) 20
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01258998What this trial is testingStudy of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01786135What this trial is testingA Safety Study of SGN-CD19A for B-Cell LymphomaWho this might be right forBurkitt LymphomaLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+2 more Seagen Inc. 64
Not applicableUnknownNCT04792593What this trial is testingSenl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWho this might be right forB-ALL Hebei Senlang Biotechnology Inc., Ltd. 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404660What this trial is testingCD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)Who this might be right forRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia Autolus Limited 153
Not applicableWithdrawnNCT00900120What this trial is testingCollecting and Storing Blood Samples From Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Looking for participantsNCT07239323What this trial is testingIn VIVO CAR-T Therapy for Relapsed/Refractory Hematological MalignanciesWho this might be right forB-Acute Lymphoblastic LeukemiaB Cell Non-Hodgkin's LymphomaMultiple Myeloma Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT01177371What this trial is testingHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00002521What this trial is testingCombination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Temple University
Early research (Phase 1)UnknownNCT04814004What this trial is testingClinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell TumorsWho this might be right forAcute Lymphoblastic LeukemiaB-cell LymphomaChronic Lymphocytic Leukemia Kai Lin Xu; Jun Nian Zheng 20
Testing effectiveness (Phase 2)UnknownNCT04534634What this trial is testingStudy of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）Who this might be right forB-cell Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 60